Form 4: STERIS SVP & GM Kenneth Kohler Reports Routine Tax Withholding on Vested Shares

Kenneth E. Kohler, Senior Vice President and General Manager of AST at STERIS plc, reported a routine disposition of 154 ordinary shares to cover tax obligations related to the vesting of restricted stock.

Summary

• Kenneth E. Kohler, SVP & GM, AST at STERIS plc (STE), reported a transaction on June 4, 2025.
• The transaction involved the disposition of 154 ordinary shares at a price of $242.1 per share.
• These 154 shares were withheld to cover tax liabilities upon the vesting of 513 restricted shares.
• The 513 restricted shares had been awarded to Mr. Kohler on June 4, 2024, and vested on June 4, 2025.
• Following this transaction, Mr. Kohler beneficially owns 6,776 ordinary shares of STERIS plc.
• Of the beneficially owned shares, 3,514 are restricted and are scheduled to vest on various dates between May 31, 2026, and June 5, 2028.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, non-discretionary transaction (tax withholding upon vesting of restricted shares) and does not indicate a change in the insider's investment thesis or company performance.

Positives

• The transaction indicates the vesting of restricted stock, which is a positive event for the employee, Kenneth E. Kohler, as it converts unvested equity into owned shares.
• The withholding of shares for tax purposes is a standard and expected procedure upon the vesting of equity awards, demonstrating compliance with tax laws.

Future Outlook

Kenneth E. Kohler holds 3,514 restricted ordinary shares of STERIS plc, which are scheduled to vest in tranches on various dates: 373 shares on May 31, 2026; 225 shares on June 2, 2026; 630 shares on June 3, 2026; 513 shares on June 4, 2026; 630 shares on June 3, 2027; 513 shares on June 4, 2027; and 630 shares on June 5, 2028.

Industry Context

This Form 4 filing details a routine insider transaction related to equity compensation, which is a common practice across all industries for executive remuneration and retention. It does not provide specific insights into broader industry trends or competitive dynamics within the healthcare products and services sector where STERIS plc operates.

Stakeholder Impact

• Shareholders: This is a routine, non-discretionary transaction and is unlikely to have a significant direct impact on the share price or shareholder value. It reflects standard executive compensation practices.
• Employees: The vesting of restricted shares and subsequent tax withholding is a common component of executive compensation packages, aligning executive interests with company performance.

Next Steps

• Future vesting of 3,514 restricted ordinary shares held by Mr. Kohler on various dates between May 31, 2026, and June 5, 2028.

Key Dates

Keywords

STERIS plc, STE, Form 4, insider transaction, stock vesting, restricted shares, tax withholding, equity compensation, Kenneth Kohler